Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Heart Failure × sacubitril and valsartan sodium hydrate drug combination × Clear all

Phase

Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Second Primary 1 Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1 Breast Diseases 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 obinutuzumab 1 acalabrutinib 1 Spironolactone 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Silesian Centre for Heart Diseases

Phase 4 Recruiting

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡